Precigen, Inc. (PGEN) Q1 2026 Earnings Call Transcript
Source: SeekingAlpha
2026-05-13 22:40:49 ET
Precigen, Inc. (PGEN) Q1 2026 Earnings Call May 13, 2026 4:30 PM EDT
Company Participants
Steven Harasym - VP & Head of Investor Relations
Helen Sabzevari - President, CEO & Director
Phil Tennant - Chief Commercial Officer
Harry Thomasian - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
Precigen, Inc. (PGEN) Q1 2026 Earnings Call Transcript
Precigen Inc.
NASDAQ: PGEN
PGEN Trading
0.6% G/L:
$5.025 Last:
2,197,667 Volume:
$4.95 Open:
PGEN Latest News
June 15, 2026 06:40:00 am
Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging
$1,632,900,063
187,173,160
1.3%
60
N/A
Biotechnology & Life Sciences
Healthcare
US
Germantown
